Physician profile
Vincent P Murphy
NPI 1851394100
$450.03
in general payments reported to CMS, 2019-2025
12 companies · $36.40 in 2025
The $36.40 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.84 · 2020: $151 · 2021: $229 · 2025: $36.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $77.42 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $71.67 | 2020-2021 | |
| Abbvie INC. | $57.62 | 2021 | |
| Biogen, INC. | $51.80 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $43.96 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $36.40 | 2025 | Dupixent |
| Acadia Pharmaceuticals INC | $30.10 | 2020 | |
| Emd Serono, INC. | $19.73 | 2021 | |
| Amneal Pharmaceuticals LLC | $18.01 | 2021 | |
| Lilly USA, LLC | $16.14 | 2021 | |
| Pfizer INC. | $14.95 | 2019 | |
| Aquestive Therapeutics, INC. | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.